SubsidieMeestersDevelopment and clinical evaluation of an end-to-end Heart Failure management solution powered by predictive AI
Implicity is developing an AI-driven platform to predict heart failure events using cardiac device data, enhancing patient care and reducing hospitalizations through tailored insights and management tools.
Projectdetails
Introduction
Heart failure is a serious chronic medical condition that impairs the heart’s ability to effectively pump blood. Globally, it has a prevalence of 64 million people.
Hospitalisation and Prevention
Heart failure patients often have to be hospitalised to manage symptoms exacerbation. These hospitalisations are preventable with data-based insights and tailored therapies. However, no holistic data platform for heart failure patients exists today.
Implicity's Solution
Implicity is set to change this situation with its suite of data-driven insights for managing heart failure.
Current Offerings
Implicity already provides a heart failure remote monitoring platform with symptoms-based decompensation detection features.
Project Development
In this project, we are developing a second module that focuses on:
- AI-based prediction of heart failure events based on cardiac implantable electronic devices’ data.
- An end-to-end software suite managing alerts, treatments, patient engagement, and workflow optimisation.
This initiative aims to enable better care and decrease the hospitalisation burden.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.488.359 |
| Totale projectbegroting | € 2.488.359 |
Tijdlijn
| Startdatum | 1-5-2025 |
| Einddatum | 30-4-2027 |
| Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- IMPLICITYpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
A new cardioprotective drug for acute treatment of myocardial infarctionResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies. | EIC Accelerator | € 2.499.999 | 2024 | Details |
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes. | EIC Accelerator | € 2.306.500 | 2024 | Details |
Autonomous robotics and digital TWIN to improve water network performancesThe project develops a robotic inspection system for water utilities, enabling autonomous pipeline assessments to enhance water quality and sustainability through a subscription-based RaaS model. | EIC Accelerator | € 2.478.210 | 2024 | Details |
Toopi Regen: Unleash the power of urine to finally scale a real closed loop and regenerative farming systemToopi Organics aims to revolutionize agriculture by up-cycling human urine into sustainable biostimulants, reducing reliance on mineral fertilizers while enhancing soil health and farmer profitability. | EIC Accelerator | € 2.396.457 | 2024 | Details |
A new cardioprotective drug for acute treatment of myocardial infarction
ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""
NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes.
Autonomous robotics and digital TWIN to improve water network performances
The project develops a robotic inspection system for water utilities, enabling autonomous pipeline assessments to enhance water quality and sustainability through a subscription-based RaaS model.
Toopi Regen: Unleash the power of urine to finally scale a real closed loop and regenerative farming system
Toopi Organics aims to revolutionize agriculture by up-cycling human urine into sustainable biostimulants, reducing reliance on mineral fertilizers while enhancing soil health and farmer profitability.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Optimize risk prediction after myocardial infarction through artificial intelligence and multidimensional evaluationThis project aims to enhance myocardial infarction risk prediction by integrating data from wearable devices, biomarkers, and AI to identify novel risk factors for improved clinical decision-making. | ERC STG | € 1.405.894 | 2024 | Details |
Novel microsensing platform for remote patient monitoringThe FORESEE project aims to advance implantable microstimulators for remote monitoring of chronic heart failure, enhancing patient care and market access for 10.5 million potential users. | EIC Transition | € 2.499.051 | 2023 | Details |
HeartGuard: Thuismonitoring van patiënt met hartfalen halveert aantal ziekenhuisopnamenDit project ontwikkelt een thuismonitoringsysteem voor hartfalenpatiënten dat met AI-gestuurde data-analyse ziekenhuisopnames met 44% kan verminderen en de zorg efficiënt verbetert. | MIT R&D Samenwerking | € 332.500 | 2023 | Details |
Boost of DiureticsHet project ontwikkelt een goedkope en effectieve methode voor thuismonitoring van hart- en longfalen, gericht op het tijdig signaleren van verslechtering om zorglasten te verlichten. | MIT Haalbaarheid | € 20.000 | 2020 | Details |
Optimize risk prediction after myocardial infarction through artificial intelligence and multidimensional evaluation
This project aims to enhance myocardial infarction risk prediction by integrating data from wearable devices, biomarkers, and AI to identify novel risk factors for improved clinical decision-making.
Novel microsensing platform for remote patient monitoring
The FORESEE project aims to advance implantable microstimulators for remote monitoring of chronic heart failure, enhancing patient care and market access for 10.5 million potential users.
HeartGuard: Thuismonitoring van patiënt met hartfalen halveert aantal ziekenhuisopnamen
Dit project ontwikkelt een thuismonitoringsysteem voor hartfalenpatiënten dat met AI-gestuurde data-analyse ziekenhuisopnames met 44% kan verminderen en de zorg efficiënt verbetert.
Boost of Diuretics
Het project ontwikkelt een goedkope en effectieve methode voor thuismonitoring van hart- en longfalen, gericht op het tijdig signaleren van verslechtering om zorglasten te verlichten.